mesalazine
Commercial- Indications
- Inflammatory bowel disease, Ulcerative colitis, Crohn's disease
Company intelligence / Profile preview
Ethypharm
Saint-Cloud Cedex, Franceethypharm.com ↗
- Ownership
- Private
- Employees
- ~1700
- Development stage
- Commercial
01
Overview
Ethypharm is a leading mid-sized international specialty pharmaceutical company that manufactures and provides essential medicines focused on CNS (severe pain and addiction) and hospital injectables.
- Therapeutic areas
- OtherPsychiatryNeurology
- Modalities
- Small moleculesInjectablesComplex oral solid forms
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Strategic partnerships in EMEA, NA, LATAM and APAC markets
Beyond the preview
Go deeper on Ethypharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ethypharm.